McGraw’s Zyprexa case sent to federal court in Brooklyn

LegalNewsLine.com
by Steve Korris
West Virginia Attorney General Darrell McGraw’s lawsuit against drug maker Eli Lilly and Company has landed in federal court at Brooklyn.
The federal Judicial Panel on Multidistrict Litigation on Oct. 18 consolidated McGraw’s suit into a mass of claims in the Eastern District of New York.
McGraw sued Eli Lilly at Mason County courthouse in [...]

Brown inherits legal drug problem

LegalNewsline.com
By Rob Luke
SACRAMENTO, Calif.–California Attorney General Bill Lockyer recently left yet another state legal-action headache for his successor, Jerry Brown, to remedy.
Several leading pharmaceutical manufacturers, including Eli Lilly & Co., AstraZeneca PLC and Bristol-Myers Squibb Co., recently revealed that they have received subpoenas from Lockyer’s office to reveal information about their anti-psychotic prescription drugs. The [...]

California AG Issues More Subpoenas Over Drug Marketing

Washington Drug Letter
Eli Lilly, Pfizer and Bristol-Myers Squibb (BMS) have joined AstraZeneca as targets of subpoenas from the California Office of the Attorney General over marketing practices for top-selling antipsychotic drugs.
The Eli Lilly subpoena is for documents relating to its marketing and promotional practices for Zyprexa (olanzapine), which is used to treat schizophrenia and bipolar [...]

California subpoenas J & J unit over drug

Los Angeles Times
From Bloomberg News
Johnson & Johnson’s Janssen unit received a subpoena from the California attorney general’s office over sales and marketing of Risperdal, a schizophrenia drug.
The subpoena was issued in September, Johnson & Johnson said in a regulatory filing. The New Brunswick, N.J.-based company said it was responding.
California authorities asked for documents on “sales [...]